certolizumab {bnma}

Trials of certolizumab pegol (CZP) for the treatment of rheumatoid arthritis in patients

Description

A dataset of 12 trials for investigating CZP for the treatment for those who had failed on disease-modifying antirheumatic drugs, including methotrexate (MTX). Data provides the number of patients who have improved and there are 6 different treatments with placebo. Mean disease duration (years) is provided as a covariate.

Usage

certolizumab

Format

A list of Outcomes, Treat, Study, N, covariate, and Treat.order

References

S. Dias, A.J. Sutton, A.E. Ades, and N.J. Welton (2013b), Heterogeneity-Subgroups, Meta-Regression, Bias, and Bias-Adjustment, Medical Decision Making 33(5):618-640. doi:10.1177/0272989X13485157